Publications by authors named "Mara Negri"

Claim this Profile
E
Effect of a Multimedia-Assisted Informed Consent Procedure on the Information Gain of Patients Undergoing Mastectomy and Implant-Based Reconstruction.
Francesca De Lorenzi, Riccardo Carbonaro, Chiara Marzorati, Eleonora Pagan, Sergio Miranda, Mara Negri

Aesthetic Plast Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients.
Emilia Montagna, Eleonora Pagan, Giuseppe Cancello, Claudia Sangalli, Vincenzo Bagnardi, Mara Negri

Anticancer Drugs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated Liposomal Doxorubicin (Caelyx) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial.
Silvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone, Vincenzo Bagnardi, Eleonora Pagan, Mara Negri

Curr Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas.
Barbara Vannata, Anna Vanazzi, Mara Negri, Sarah Jayne Liptrott, Anna Amalia Bartosek

Hematol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
Simona Sammassimo, Giancarlo Pruneri, Giovanna Andreola, Juan Montoro, Sara Steffanoni, Mara Negri

Hematol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-Hodgkin's lymphoma: a retrospective single-centre study.
Giovanni Martinelli, Juan Montoro, Anna Vanazzi, Giovanna Andreola, Sarah Liptrott, Mara Negri

Hematol Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma.
Juan Montoro, Giovanna Andreola, Angelo Gardellini, Aleksandra Babic, Mara Negri

Transfus Apher Sci· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who should be really considered as a poor mobilizer in the plerixafor era?
Giovanna Andreola, Anna Vanazzi, Davide Radice, Aleksandra Babic, Cristina Rabascio, Mara Negri

Transfus Apher Sci· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.
Giovanna Andreola, Aleksandra Babic, Cristina Rabascio, Mara Negri, Giovanni Martinelli

Eur J Haematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.
Simona Bassi, Cristina Rabascio, Luca Nassi, Sara Steffanoni, Aleksandra Babic, Mara Negri

Transfus Apher Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.
Paola Bertazzoni, Cristina Rabascio, Federica Gigli, Liliana Calabrese, Davide Radice, Mara Negri

Leuk Lymphoma· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis